Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
作者信息
Rybak Michael J, Le Jennifer, Lodise Thomas, Levine Donald, Bradley John, Liu Catherine, Mueller Bruce, Pai Manjunath, Wong-Beringer Annie, Rotschafer John C, Rodvold Keith, Maples Holly D, Lomaestro Benjamin M
机构信息
Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, Michigan, USA.
School of Medicine, Wayne State University, Detroit, Michigan, USA.
出版信息
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):281-284. doi: 10.1093/jpids/piaa057.
Abstract
摘要
相似文献
1
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.执行摘要：针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会和传染病药师协会的修订共识指南及综述
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):281-284. doi: 10.1093/jpids/piaa057.
2
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会修订的共识指南及综述
Clin Infect Dis. 2020 Sep 12;71(6):1361-1364. doi: 10.1093/cid/ciaa303.
3
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.执行摘要：针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会的修订共识指南与综述
Pharmacotherapy. 2020 Apr;40(4):363-367. doi: 10.1002/phar.2376. Epub 2020 Mar 29.
4
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会的修订共识指南及综述
Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
5
Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin.临床医生指南要点：万古霉素的治疗药物监测。
J Hosp Med. 2020 Dec;15(12):740-742. doi: 10.12788/jhm.3507.
6
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.成人万古霉素治疗药物监测：美国卫生系统药剂师学会、美国感染病学会和感染病学会药剂师协会共识推荐总结。
Pharmacotherapy. 2009 Nov;29(11):1275-9. doi: 10.1592/phco.29.11.1275.
7
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.万古霉素治疗指南：美国传染病学会、美国卫生系统药师协会和传染病药师协会共识推荐摘要
Clin Infect Dis. 2009 Aug 1;49(3):325-7. doi: 10.1086/600877.
8
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.成人患者万古霉素的治疗监测：美国卫生系统药师协会、美国传染病学会和传染病药师协会的共识综述
Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434.
9
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.美国传染病学会治疗成人和儿童耐甲氧西林金黄色葡萄球菌感染的临床实践指南：执行摘要。
Clin Infect Dis. 2011 Feb 1;52(3):285-92. doi: 10.1093/cid/cir034.
10
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.美国传染病学会发布的耐甲氧西林金黄色葡萄球菌感染成人和儿童治疗临床实践指南。
Clin Infect Dis. 2011 Feb 1;52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4.
引用本文的文献
1
Clinical validation of an innovative dried whole-blood spot method to quantify simultaneously vancomycin and creatinine in adult patients.一种创新的干血斑法用于同时定量成年患者万古霉素和肌酐的临床验证。
J Antimicrob Chemother. 2025 Apr 2;80(4):1097-1107. doi: 10.1093/jac/dkaf041.
2
Population Pharmacokinetics and Dosing Optimization of Norvancomycin for Chinese Patients with Community-Acquired Pneumonia.中国社区获得性肺炎患者去甲万古霉素的群体药代动力学及给药方案优化
Infect Drug Resist. 2024 Dec 27;17:5881-5893. doi: 10.2147/IDR.S496776. eCollection 2024.
3
Population Pharmacokinetics of Vancomycin in Intensive Care Patients with the Time-Varying Status of Temporary Mechanical Circulatory Support or Continuous Renal Replacement Therapy.万古霉素在接受临时机械循环支持或持续肾脏替代治疗且状态随时间变化的重症监护患者中的群体药代动力学。
Infect Dis Ther. 2024 Dec;13(12):2617-2635. doi: 10.1007/s40121-024-01071-5. Epub 2024 Nov 14.
4
Comparing Two Vancomycin Loading Dose Regimens in Patients With Obesity: A Single-Center Prospective Clinical Trial.比较肥胖患者的两种万古霉素负荷剂量方案：一项单中心前瞻性临床试验。
Cureus. 2024 Oct 4;16(10):e70849. doi: 10.7759/cureus.70849. eCollection 2024 Oct.
5
What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value.评估疗效的最佳万古霉素治疗药物监测参数是什么？对实验数据的批判性综述及对个体患者最低抑菌浓度值需求的评估。
Microorganisms. 2023 Feb 24;11(3):567. doi: 10.3390/microorganisms11030567.
6
Optimal Use and Need for Therapeutic Drug Monitoring of Teicoplanin in Children: A Systematic Review.泰利霉素在儿童中的最佳使用和治疗药物监测需求：系统评价。
J Korean Med Sci. 2023 Feb 20;38(7):e62. doi: 10.3346/jkms.2023.38.e62.
7
Vancomycin area under the curve/minimum inhibitory concentration and trough level concordance-evaluation on an urban health unit.城市卫生单位中万古霉素曲线下面积/最低抑菌浓度与谷浓度的一致性评估
Ther Adv Infect Dis. 2022 Nov 28;9:20499361221140368. doi: 10.1177/20499361221140368. eCollection 2022 Jan-Dec.
8
Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program.门诊肠外抗菌治疗项目中在家接受治疗的患者万古霉素持续输注的临床疗效与安全性
Antibiotics (Basel). 2022 May 23;11(5):702. doi: 10.3390/antibiotics11050702.
9
Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis.奥马环素在大鼠耐甲氧西林金黄色葡萄球菌骨髓炎中的活性。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0170321. doi: 10.1128/AAC.01703-21. Epub 2021 Nov 1.
10
Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance.中国肾功能增强患者万古霉素的群体药代动力学建模与剂量优化
Antibiotics (Basel). 2021 Oct 12;10(10):1238. doi: 10.3390/antibiotics10101238.
本文引用的文献
1
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会的修订共识指南及综述
Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
2
The periodic health examination. Canadian Task Force on the Periodic Health Examination.定期健康检查。加拿大定期健康检查特别工作组。
Can Med Assoc J. 1979 Nov 3;121(9):1193-254.
Zotero 插件